UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): | October 22, 2009 |
MKS Instruments, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
Massachusetts | 000-23621 | 04-2277512 |
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
of incorporation) | File Number) | Identification No.) |
2 Tech Drive, Suite 201, Andover, Massachusetts | 01810 | |
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
Registrants telephone number, including area code: | 978-645-5500 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On October 22, 2009 MKS Instruments, Inc. announced its financial results for the quarter ended September 30, 2009. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 of the Exchange Act, as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release dated October 22, 2009.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MKS Instruments, Inc. | ||||
October 22, 2009 | By: |
Ronald C. Weigner
|
||
|
||||
Name: Ronald C. Weigner | ||||
Title: VP, CFO & Treasurer |
Exhibit Index
Exhibit No. | Description | |
|
|
|
99.1
|
Press Release dated October 22, 2009 |
(MKS LOGO)
EXHIBIT 99.1
Contact: Ronald C. Weigner
Vice President, Chief Financial Officer & Treasurer
Telephone: 978.645.5576
MKS Instruments Reports Q3 2009 Financial Results
Andover, Mass., October 22, 2009 MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today reported third quarter 2009 financial results.
Sales were $106.3 million, up 34% percent from $79.2 million in the second quarter of 2009, and down 33% percent from $157.4 million in the third quarter of 2008.
Third quarter net loss was $4.0 million, or $(0.08) per basic share, compared to a net loss of $207.2 million, or $(4.20) per basic share, in the second quarter of 2009 and net income of $6.8 million, or $0.14 per diluted share, in the third quarter of 2008. The third quarter 2009 net loss includes the effect of a lower effective income tax benefit for 2009.
Non-GAAP net earnings, which exclude amortization of acquired intangible assets and special items, totaled $1.6 million, or $0.03 per diluted share, compared to a net loss of $9.2 million, or $(0.19) per basic share, in the second quarter of 2009 and net income of $8.9 million, or $0.18 per diluted share, in the third quarter of 2008.
Leo Berlinghieri, Chief Executive Officer and President, said, We have seen 34% sequential revenue growth this quarter and have adjusted production to meet the increased demand. The increase in our revenue primarily reflects the higher levels of sales at our semiconductor OEM and device customers and is consistent with recent announcements by industry research firms that chip unit sales and semiconductor front end equipment utilization rates are increasing. Based on current customer activity, we anticipate that business in the fourth quarter of 2009 will continue to show improvement. We estimate that fourth quarter sales could range from $120 to $135 million. At these volumes, GAAP net income could range from $0.06 to $0.19 per share on approximately 51 million shares outstanding. Non-GAAP net earnings could range from $0.04 to $0.11 per share. The non-GAAP net earnings are lower than our GAAP net income due to a higher tax rate on a non-GAAP basis.
Management will discuss third quarter financial results on a conference call today at 8:30 a.m. (Eastern Time). Dial-in numbers are 1-888-549-7880 for domestic callers and 480-629-9866 for international callers. The call will be broadcast live and available for replay at www.mksinstruments.com. To hear a telephone replay through October 29, 2009, dial 303-590-3030, pass code 4163117#.
The financial results that exclude certain charges and special items are not in accordance with Accounting Principles Generally Accepted in the United States of America (GAAP). MKS management believes the presentation of non-GAAP financial measures, which exclude costs associated with acquisitions and special items and include a normalized income tax rate, is useful to investors for comparing prior periods and analyzing ongoing business trends and operating results.
MKS Instruments, Inc. is a global provider of instruments, subsystems and process control solutions that measure, control, power, monitor and analyze critical parameters of advanced manufacturing processes to improve process performance and productivity. Our products are derived from our core competencies in pressure measurement and control, materials delivery, gas composition analysis, electrostatic charge management, control and information technology, power and reactive gas generation, and vacuum technology. Our primary served markets are manufacturers of capital equipment for semiconductor devices, and for other thin film applications including flat panel displays, solar cells, data storage media, and other advanced coatings. We also leverage our technology in other markets with advanced manufacturing applications including medical equipment, pharmaceutical manufacturing, energy generation, and environmental monitoring.
This release contains projections or other forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27 of the Securities Act, and Section 21E of the Securities Exchange Act regarding MKS future growth and the future financial performance of MKS. These projections or statements are only predictions. Actual events or results may differ materially from those in the projections or other forward-looking statements set forth herein. Among the important factors that could cause actual events to differ materially from those in the projections or other forward-looking statements are the fluctuations in capital spending in the semiconductor industry, fluctuations in net sales to MKS major customers, potential fluctuations in quarterly results, the challenges, risks and costs involved with integrating the operations of MKS and any acquired companies, dependence on new product development, rapid technological and market change, acquisition strategy, manufacturing and sourcing risks, volatility of stock price, international operations, financial risk management, and future growth subject to risks. Readers are referred to MKS filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K, for a discussion of these and other important risk factors concerning MKS and its operations. MKS is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
###
MKS Instruments, Inc.
Unaudited Consolidated Statements of Operations
(In thousands, except per share data)
Three Months Ended | ||||||||||||
September 30, 2009 | September 30, 2008 | June 30, 2009 | ||||||||||
Net sales |
$ | 106,262 | $ | 157,364 | $ | 79,155 | ||||||
Cost of sales |
66,783 | 94,425 | 53,627 | |||||||||
Gross profit |
39,479 | 62,939 | 25,528 | |||||||||
Research and development |
12,114 | 19,228 | 12,285 | |||||||||
Selling, general and administrative |
24,385 | 33,760 | 25,909 | |||||||||
Amortization of acquired intangible assets |
871 | 1,963 | 1,011 | |||||||||
Goodwill and asset impairment charges |
| | 208,497 | |||||||||
Restructuring |
168 | | 68 | |||||||||
Income (loss) from operations |
1,941 | 7,988 | (222,242 | ) | ||||||||
Gain on investments |
| 506 | | |||||||||
Interest income, net |
263 | 1,326 | 213 | |||||||||
Income (loss) before income taxes |
2,204 | 9,820 | (222,029 | ) | ||||||||
Provision (benefit) for income taxes |
6,177 | 3,029 | (14,895 | ) | ||||||||
Net income (loss) |
$ | (3,973 | ) | $ | 6,791 | $ | (207,134 | ) | ||||
Net income (loss) per share: |
||||||||||||
Basic |
$ | (0.08 | ) | $ | 0.14 | $ | (4.20 | ) | ||||
Diluted |
$ | (0.08 | ) | $ | 0.14 | $ | (4.20 | ) | ||||
Weighted average shares outstanding: |
||||||||||||
Basic |
49,461 | 48,730 | 49,307 | |||||||||
Diluted |
50,298 | 49,898 | 49,307 | |||||||||
The following supplemental Non-GAAP earnings
information is presented to aid in understanding
MKS operating results: |
||||||||||||
GAAP net income (loss) |
$ | (3,973 | ) | $ | 6,791 | $ | (207,134 | ) | ||||
Adjustments (net of tax, if applicable): |
||||||||||||
Amortization of acquired intangible assets |
871 | 1,963 | 1,011 | |||||||||
Restructuring and related items (Note 1) |
168 | | 68 | |||||||||
Goodwill and asset impairment charges (Note 2) |
| | 208,497 | |||||||||
Expense for income taxes (Note 3) |
| 819 | | |||||||||
Proforma tax adjustments |
4,497 | (709 | ) | (11,629 | ) | |||||||
Non-GAAP net earnings (loss) (Note 4) |
$ | 1,563 | $ | 8,864 | $ | (9,187 | ) | |||||
Non-GAAP net earnings (loss) per share (Note 4) |
$ | 0.03 | $ | 0.18 | $ | (0.19 | ) | |||||
Weighted average shares outstanding diluted |
50,298 | 49,898 | 49,307 |
Note 1: The three month periods ended September 30, 2009 and June 30, 2009 include $168 and $68, respectively, of restructuring charges primarily for severance related costs.
Note 2: The three month period ended June 30, 2009 includes a $208,497 write-down for the impairment of goodwill, intangible assets and other long-lived assets.
Note 3: The three month period ended September 30, 2008 includes a net tax expense for discrete items of $819 attributable to the booking of a valuation allowance on state tax credits of $2,651 partially offset by a benefit of $1,832 for discrete items related to the reversal of FIN 48 reserve items as a result of a statute of limitations expiration.
Note 4: The Non-GAAP net earnings (loss) and Non-GAAP net earnings (loss) per share amounts exclude amortization of acquired intangible assets, acquisition and disposition related charges and special items, net of applicable income taxes.
MKS Instruments, Inc.
Unaudited Consolidated Statements of Operations
(In thousands, except per share data)
Nine Months Ended | ||||||||
September 30, | ||||||||
2009 | 2008 | |||||||
Net sales |
$ | 262,136 | $ | 521,814 | ||||
Cost of sales |
186,780 | 306,480 | ||||||
Gross profit |
75,356 | 215,334 | ||||||
Research and development |
39,862 | 59,263 | ||||||
Selling, general and administrative |
78,516 | 100,282 | ||||||
Amortization of acquired intangible assets |
3,535 | 7,052 | ||||||
Goodwill and asset impairment charges |
208,497 | | ||||||
Restructuring |
5,856 | | ||||||
Income (loss) from operations |
(260,910 | ) | 48,737 | |||||
Impairment of investments |
| (906 | ) | |||||
Interest income, net |
1,485 | 5,138 | ||||||
Income (loss) before income taxes |
(259,425 | ) | 52,969 | |||||
Provision (benefit) for income taxes |
(31,819 | ) | 16,562 | |||||
Net income (loss) |
$ | (227,606 | ) | $ | 36,407 | |||
Net income (loss) per share: |
||||||||
Basic |
$ | (4.62 | ) | $ | 0.73 | |||
Diluted |
$ | (4.56 | ) | $ | 0.71 | |||
Weighted average shares outstanding: |
||||||||
Basic |
49,254 | 50,051 | ||||||
Diluted |
49,942 | 51,112 | ||||||
The following supplemental Non-GAAP earnings information is
presented to aid in understanding MKS operating results: |
||||||||
GAAP net income (loss) |
$ | (227,606 | ) | $ | 36,407 | |||
Adjustments (net of tax, if applicable): |
||||||||
Amortization of acquired intangible assets |
3,535 | 7,052 | ||||||
Excess & obsolete inventory adjustment (Note 1) |
12,900 | | ||||||
Restructuring and related items (Note 2) |
4,558 | | ||||||
Goodwill and asset impairment charges (Note 3) |
208,497 | | ||||||
Foreign exchange gain from legal entity restructuring (Note 4) |
| (2,669 | ) | |||||
Expense (benefit) for income taxes (Note 5) |
(6,370 | ) | 819 | |||||
Proforma tax adjustments |
(14,179 | ) | (1,630 | ) | ||||
Non-GAAP net earnings (loss) (Note 6) |
$ | (18,665 | ) | $ | 39,979 | |||
Non-GAAP net earning (loss) per share (Note 6) |
$ | (0.37 | ) | $ | 0.78 | |||
Weighted average shares outstanding diluted |
49,942 | 51,112 |
Note 1: Cost of Sales for the nine month period ended September 30, 2009 includes $12,900 of
special charges for excess, obsolete and committed inventory purchases.
Note 2: The nine month period ended September 30, 2009 includes $5,856 of restructuring charges
primarily for severance related costs offset by a credit of $1,298 for the reversal of previously
expensed equity compensation charges of terminated employees.
Note 3: The nine month period ended September 30, 2009 includes a $208,497 write-down for the
impairment of goodwill, intangible assets and other long-lived assets.
Note 4: Selling, general and administrative expenses for the nine month period ended September 30,
2008 includes a foreign exchange gain of $2,669 related to the Companys legal entity restructuring
of certain foreign operations.
Note 5: The nine month period ended September 30, 2009 includes a benefit of $6,370 attributable
to the reversal of FIN 48 reserve items as a result of a Federal audit close. The nine month
period ended September 30, 2008 includes a net tax expense for discrete items of $819 attributable
to the booking of a valuation allowance on state tax credits of $2,651 partially offset by a
benefit of $1,832 for discrete items related to the reversal of FIN 48 reserve items as a result of
a statute of limitations expiration.
Note 6: The Non-GAAP net earnings (loss) and Non-GAAP net earnings (loss) per share amounts
exclude amortization of acquired intangible assets, acquisition and disposition related charges and
special items, net of applicable income taxes.
MKS Instruments, Inc.
Unaudited Consolidated Balance Sheet
(In thousands)
September 30, 2009 | December 31, 2008 | |||||||
ASSETS |
||||||||
Cash and short-term investments |
$ | 265,218 | $ | 278,869 | ||||
Trade accounts receivable |
72,166 | 85,350 | ||||||
Inventories |
116,156 | 131,519 | ||||||
Other current assets |
63,013 | 32,990 | ||||||
Total current assets |
516,553 | 528,728 | ||||||
Property, plant and equipment, net |
70,193 | 82,017 | ||||||
Goodwill |
144,511 | 337,765 | ||||||
Other acquired intangible assets |
5,835 | 21,069 | ||||||
Other assets |
13,333 | 15,360 | ||||||
Total assets |
$ | 750,425 | $ | 984,939 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Short-term debt |
$ | 10,563 | $ | 18,678 | ||||
Accounts payable |
22,148 | 19,320 | ||||||
Accrued expenses and other liabilities |
31,805 | 37,937 | ||||||
Total current liabilities |
64,516 | 75,935 | ||||||
Long-term debt |
118 | 396 | ||||||
Other long-term liabilities |
18,704 | 21,910 | ||||||
Stockholders equity: |
||||||||
Common stock |
113 | 113 | ||||||
Additional paid-in capital |
642,987 | 637,938 | ||||||
Retained earnings |
13,822 | 241,428 | ||||||
Other stockholders equity |
10,165 | 7,219 | ||||||
Total stockholders equity |
667,087 | 886,698 | ||||||
Total liabilities and stockholders equity |
$ | 750,425 | $ | 984,939 | ||||